{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:11:41Z","timestamp":1779372701222,"version":"3.53.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Doctoral Research Fund of Beijing Rehabilitation Hospital of Capital Medical University","award":["2020-060"],"award-info":[{"award-number":["2020-060"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04940-1","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T11:58:32Z","timestamp":1764935912000},"page":"1979-1988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ZSTK474 suppresses bladder cancer cell migration and invasion via PI3K\/Akt\/Girdin pathway: an in vitro study"],"prefix":"10.1007","volume":"58","author":[{"given":"Zhaoxia","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefu","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiejun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"3","key":"4940_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660. (Epub 2021 Feb 4 PMID: 33538338)","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4940_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65(1):5\u201329. https:\/\/doi.org\/10.3322\/caac.21254","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4940_CR3","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0022-5347(17)42387-1","volume":"139","author":"H R\u00fcbben","year":"1988","unstructured":"R\u00fcbben H, Lutzeyer W, Fischer N, Deutz F, Lagrange W, Giani G (1988) Natural history and treatment of low and high risk superficial bladder tumors. J Urol 139(2):283\u2013285. https:\/\/doi.org\/10.1016\/s0022-5347(17)42387-1","journal-title":"J Urol"},{"issue":"5","key":"4940_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s00262-004-0621-x","volume":"54","author":"EA Schenk-Braat","year":"2005","unstructured":"Schenk-Braat EA, Bangma CH (2005) Immunotherapy for superficial bladder cancer. Cancer Immunol Immunother 54(5):414\u2013423. https:\/\/doi.org\/10.1007\/s00262-004-0621-x","journal-title":"Cancer Immunol Immunother"},{"key":"4940_CR5","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1100\/tsw.2006.404","volume":"6","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ (2006) Natural history, recurrence, and progression in superficial bladder cancer. Sci World J 6:2617\u20132625. https:\/\/doi.org\/10.1100\/tsw.2006.404","journal-title":"Sci World J"},{"issue":"3","key":"4940_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030651","volume":"16","author":"Pierluigi Russo","year":"2024","unstructured":"Pierluigi Russo, Giuseppe Palermo, Roberto Iacovelli et al (2024) Comparison of PIV and other immune inflammation markers of oncological and survival outcomes in patients undergoing radical cystectomy. Cancers (Basel) 16(3):651. https:\/\/doi.org\/10.3390\/cancers16030651","journal-title":"Cancers (Basel)"},{"issue":"3","key":"4940_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","volume":"71","author":"J Alfred Witjes","year":"2017","unstructured":"Alfred Witjes J, Lebret T, Comp\u00e9rat EM et al (2017) Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 71(3):462\u2013475. https:\/\/doi.org\/10.1016\/j.eururo.2016.06.020","journal-title":"Eur Urol"},{"issue":"21","key":"4940_CR8","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1200\/JCO.2005.07.757","volume":"23","author":"H von der Maase","year":"2005","unstructured":"von der Maase H, Sengelov L, Roberts JT et al (2005) Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 23(21):4602\u20134608. https:\/\/doi.org\/10.1200\/JCO.2005.07.757","journal-title":"J Clin Oncol"},{"issue":"7492","key":"4940_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network (2014) Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507(7492):315\u2013322. https:\/\/doi.org\/10.1038\/nature12965","journal-title":"Nature"},{"issue":"4","key":"4940_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2174\/1568009618666180911101310","volume":"19","author":"J Liu","year":"2019","unstructured":"Liu J, Tan X, Zhao W et al (2019) In vitro and in vivo antimetastatic effects of ZSTK474 on prostate cancer DU145 cells. Curr Cancer Drug Targets 19(4):321\u2013329. https:\/\/doi.org\/10.2174\/1568009618666180911101310","journal-title":"Curr Cancer Drug Targets"},{"issue":"2","key":"4940_CR11","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/or.2018.6469","volume":"40","author":"S Wang","year":"2018","unstructured":"Wang S, Lei Y, Cai Z et al (2018) Girdin regulates the proliferation and apoptosis of pancreatic cancer cells via the PI3K\/Akt signalling pathway. Oncol Rep 40(2):599\u2013608. https:\/\/doi.org\/10.3892\/or.2018.6469","journal-title":"Oncol Rep"},{"issue":"6759","key":"4940_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/46319","volume":"402","author":"EH Walker","year":"1999","unstructured":"Walker EH, Perisic O, Ried C, Stephens L, Williams RL (1999) Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature 402(6759):313\u2013320. https:\/\/doi.org\/10.1038\/46319","journal-title":"Nature"},{"issue":"8","key":"4940_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/jnci\/djj133","volume":"98","author":"S Yaguchi","year":"2006","unstructured":"Yaguchi S, Fukui Y, Koshimizu I et al (2006) Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor. J Natl Cancer Inst 98(8):545\u2013556. https:\/\/doi.org\/10.1093\/jnci\/djj133","journal-title":"J Natl Cancer Inst"},{"key":"4940_CR14","unstructured":"GraphPad Prism, version 4. Available online: http:\/\/www.graphpad.com\/scientific-software\/prism\/. Accessed on 26, June, 2013"},{"issue":"2","key":"4940_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/md9020154","volume":"9","author":"D Kong","year":"2011","unstructured":"Kong D, Yamori T, Kobayashi M, Duan H (2011) Antiproliferative and antiangiogenic activities of smenospongine, a marine sponge sesquiterpene aminoquinone. Mar Drugs 9(2):154\u2013161. https:\/\/doi.org\/10.3390\/md9020154","journal-title":"Mar Drugs"},{"issue":"5","key":"4940_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ejca.2008.12.007","volume":"45","author":"D Kong","year":"2009","unstructured":"Kong D, Okamura M, Yoshimi H, Yamori T (2009) Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor. Eur J Cancer 45(5):857\u2013865. https:\/\/doi.org\/10.1016\/j.ejca.2008.12.007","journal-title":"Eur J Cancer"},{"key":"4940_CR17","unstructured":"ImageJ, version 1.47. Available online: http:\/\/rsbweb.nih.gov\/ij\/"},{"issue":"2","key":"4940_CR18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/annonc\/mdr156","volume":"23","author":"MD Galsky","year":"2012","unstructured":"Galsky MD, Chen GJ, Oh WK et al (2012) Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma. Ann Oncol 23(2):406\u2013410. https:\/\/doi.org\/10.1093\/annonc\/mdr156","journal-title":"Ann Oncol"},{"issue":"6","key":"4940_CR19","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/sj.leu.2404245","volume":"20","author":"AM Martelli","year":"2006","unstructured":"Martelli AM, Ny\u00e5kern M, Tabellini G et al (2006) Phosphoinositide 3-kinase\/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. Leukemia 20(6):911\u2013928. https:\/\/doi.org\/10.1038\/sj.leu.2404245","journal-title":"Leukemia"},{"issue":"9","key":"4940_CR20","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/aps.2010.150","volume":"31","author":"DX Kong","year":"2010","unstructured":"Kong DX, Yamori T (2010) ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39 drug discovery system. Acta Pharmacol Sin 31(9):1189\u20131197. https:\/\/doi.org\/10.1038\/aps.2010.150","journal-title":"Acta Pharmacol Sin"},{"issue":"15","key":"4940_CR21","doi-asserted-by":"publisher","first-page":"19897","DOI":"10.18632\/oncotarget.7658","volume":"7","author":"Y Wang","year":"2016","unstructured":"Wang Y, Liu J, Qiu Y et al (2016) ZSTK474, a specific class I phosphatidylinositol 3-kinase inhibitor, induces G1 arrest and autophagy in human breast cancer MCF-7 cells. Oncotarget 7(15):19897\u201319909. https:\/\/doi.org\/10.18632\/oncotarget.7658","journal-title":"Oncotarget"},{"issue":"3","key":"4940_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.devcel.2005.08.001","volume":"9","author":"A Enomoto","year":"2005","unstructured":"Enomoto A, Murakami H, Asai N et al (2005) Akt\/PKB regulates actin organization and cell motility via Girdin\/APE. Dev Cell 9(3):389\u2013402. https:\/\/doi.org\/10.1016\/j.devcel.2005.08.001","journal-title":"Dev Cell"},{"issue":"5","key":"4940_CR23","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1158\/0008-5472.CAN-07-5111","volume":"68","author":"P Jiang","year":"2008","unstructured":"Jiang P, Enomoto A, Jijiwa M et al (2008) An actin-binding protein Girdin regulates the motility of breast cancer cells. Cancer Res 68(5):1310\u20131318. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-5111","journal-title":"Cancer Res"},{"issue":"3","key":"4940_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/ncb1695","volume":"10","author":"T Kitamura","year":"2008","unstructured":"Kitamura T, Asai N, Enomoto A et al (2008) Regulation of VEGF-mediated angiogenesis by the Akt\/PKB substrate Girdin. Nat Cell Biol 10(3):329\u2013337. https:\/\/doi.org\/10.1038\/ncb1695","journal-title":"Nat Cell Biol"},{"issue":"6","key":"4940_CR25","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuron.2009.08.015","volume":"63","author":"A Enomoto","year":"2009","unstructured":"Enomoto A, Asai N, Namba T et al (2009) Roles of disrupted-in-schizophrenia 1-interacting protein girdin in postnatal development of the dentate gyrus. Neuron 63(6):774\u2013787. https:\/\/doi.org\/10.1016\/j.neuron.2009.08.015","journal-title":"Neuron"},{"issue":"5","key":"4940_CR26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/0008-5472.CAN-14-1317","volume":"75","author":"Y Yamamura","year":"2015","unstructured":"Yamamura Y, Asai N, Enomoto A et al (2015) Akt-Girdin signaling in cancer-associated fibroblasts contributes to tumor progression. Cancer Res 75(5):813\u2013823. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-1317","journal-title":"Cancer Res"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04940-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04940-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04940-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:41:43Z","timestamp":1779370903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04940-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["4940"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04940-1","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}